An aging global population, rising affluence, and expanded access to eye care plus increased computer use and more effective dry eye products are expected to fuel double-digit compounded growth in the dry eye products market during the next five years. We expect much of this growth to occur in the pharmaceutical segment where new pipeline therapies are poised to join two very successful commercialized Rx products.